EGFR and adenocarcinoma: The epidermal growth factor receptor (EGFR) is a well-characterized mutated oncogene in non-small cell lung cancer (NSCLC) that is found in ~10–20% of cases in western countries and is associated predominantly with adenocarcinoma histology.